SYED GARDEZI: Open Payments
NPI 1689637464 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 46 payments from 13 companies in 2025. Trend: 2023 $1,169 · 2024 $843 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $138 |
| Novo Nordisk Inc | 5 | $107 |
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| Exact Sciences Corporation | 5 | $92 |
| GlaxoSmithKline, LLC. | 5 | $85 |
| Lilly USA, LLC | 4 | $81 |
| Amgen Inc. | 4 | $77 |
| Dexcom, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $39 |
| PFIZER INC. | 1 | $20 |
Products named: Kerendia, Ozempic, The Cologuard Plus Collection Kit, AIRSUPRA, MOUNJARO, OTEZLA, TRELEGY ELLIPTA, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
